The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo

Placide Mbala-Kingebeni; Anne W Rimoin; Cris Kacita; Laurens Liesenborghs; Jean B Nachega; Jason Kindrachuk

doi:10.1371/journal.pgph.0003171

The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo

PLOS Glob Public Health. 2024 Jun 7;4(6):e0003171. doi: 10.1371/journal.pgph.0003171. eCollection 2024.

Authors

Placide Mbala-Kingebeni^{1

2}, Anne W Rimoin^{3

4}, Cris Kacita⁵, Laurens Liesenborghs^{6

7}, Jean B Nachega^{8

9

10}, Jason Kindrachuk^{11

12}

Affiliations

¹ Pathogen Genomics Laboratory, Epidemiology and Global Health Department, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
² Service de Microbiologie, Cliniques Universitaires, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
³ Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America.
⁴ UCLA-DRC Health Research and Training Program, UCLA Fielding School of Public Health, Los Angeles, California, United States of America.
⁵ Monkeypox and Viral Hemorrhagic Fever Control Program, Ministry of Public Health, Kinshasa, Democratic Republic of the Congo.
⁶ Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
⁷ Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁸ Departments of Epidemiology, Infectious Diseases and Microbiology and Center for Global Health, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America.
⁹ Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Center for Global Health, Johns Hopkins University Baltimore, Baltimore, Maryland, United States of America.
¹⁰ Department of Medicine, Division of Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa.
¹¹ Department of Medical Microbiology & Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
¹² Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.

No abstract available

Grants and funding

This work was supported by the International Mpox Research Consortium (IMReC) through funding from the Canadian Institutes of Health Research and International Development Research Centre (grant no. MRR-184813 to JK, PMK); Department of Defense, Defense Threat Reduction Agency (Monkeypox Threat Reduction Network grant #HDTRA1-21-1-0040 to AWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.